Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jan;141(1):445–448.e4. doi: 10.1016/j.jaci.2017.08.026

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 The Authors

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Fig E1 — Additional prediction model figures. Patients with early RA (n = 32) had baseline ESR levels, CRP levels, and DAS28 scores calculated, and disease activity parameters were assessed at 6 months after diagnosis and initiation of treatment. A, Plot depicts age- and sex-corrected multiple regression between baseline ESR levels, CRP levels, and DAS28 scores and DAS28 scores at 6 months. B, Relationship between the probability of achieving a good EULAR response at 6 months and baseline ESR levels, CRP levels, and DAS28 scores (nominal logistic regression age and sex corrected). C, Plot depicts the relationship between the probability of receiving additional glucocorticoids in the first 6 months after diagnosis and baseline ESR levels, CRP levels, and DAS28 scores. Numbers denote numbers of additional glucocorticoid administrations (0-3) in the first 6 months. Baseline ESR levels, CRP levels, and DAS28 scores did not significantly predict additional glucocorticoid requirements (P = .345, P = .615, and P = .699, respectively; ordinal logistic regression with bootstrap probabilities included).